A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

NCT07628049 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

1456

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections+Metapneumovirus

Interventions

BIOLOGICAL: RSV/hMPV_V low dose vaccine
BIOLOGICAL: RSV/hMPV_V medium dose vaccine
BIOLOGICAL: RSV/hMPV_V high dose vaccine
BIOLOGICAL: RSV/hMPV_W low dose vaccine
BIOLOGICAL: RSV/hMPV_W medium dose vaccine
BIOLOGICAL: RSV/hMPV_W high dose vaccine
BIOLOGICAL: RSV/hMPV_X low dose vaccine
BIOLOGICAL: RSV/hMPV_X medium dose vaccine
BIOLOGICAL: RSV/hMPV_X high dose vaccine
BIOLOGICAL: hMPV_Y low dose vaccine
BIOLOGICAL: hMPV_Y medium dose vaccine
BIOLOGICAL: hMPV_Y high dose vaccine
BIOLOGICAL: hMPV_Z low dose vaccine
BIOLOGICAL: hMPV_Z medium dose vaccine
BIOLOGICAL: hMPV_Z high dose vaccine
BIOLOGICAL: Control vaccine
COMBINATION_PRODUCT: Placebo

Sponsor

GlaxoSmithKline